480 related articles for article (PubMed ID: 17113929)
21. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
[TBL] [Abstract][Full Text] [Related]
22. Effect of morphine on the release of excitatory amino acids in the rat hind instep: Pain is modulated by the interaction between the peripheral opioid and glutamate systems.
Jin YH; Nishioka H; Wakabayashi K; Fujita T; Yonehara N
Neuroscience; 2006; 138(4):1329-39. PubMed ID: 16473472
[TBL] [Abstract][Full Text] [Related]
23. Involvement of opioid receptors in the CGRP-induced antinociception in the nucleus accumbens of rats.
Li L; Wang X; Yu LC
Brain Res; 2010 Sep; 1353():53-9. PubMed ID: 20659434
[TBL] [Abstract][Full Text] [Related]
24. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
27. Opioid modulation of ferret vagal afferent mechanosensitivity.
Page AJ; O'Donnell TA; Blackshaw LA
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G963-70. PubMed ID: 18258789
[TBL] [Abstract][Full Text] [Related]
28. Opioid receptor desensitization contributes to thermal hyperalgesia in infant rats.
Liu JG; Rovnaghi CR; Garg S; Anand KJ
Eur J Pharmacol; 2004 May; 491(2-3):127-36. PubMed ID: 15140629
[TBL] [Abstract][Full Text] [Related]
29. [The mu, delta and kappa properties of various opioids].
Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the involvement of μ-opioid and δ-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Zeni G; Nogueira CW
Behav Pharmacol; 2010 Oct; 21(7):621-6. PubMed ID: 20729717
[TBL] [Abstract][Full Text] [Related]
31. [Differentiation of antinociceptive effects of mu, delta and kappa agonists using heat, chemical and mechanical nociception].
Murakawa K; Noma K; Matsuda M; Maeda S; Tashiro C; Izumi R
Masui; 1996 Aug; 45(8):937-42. PubMed ID: 8818088
[TBL] [Abstract][Full Text] [Related]
32. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
[TBL] [Abstract][Full Text] [Related]
34. Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats.
Yan Y; Yu LC
J Neurosci Res; 2004 Jul; 77(1):148-52. PubMed ID: 15197748
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
36. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
37. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
38. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
39. Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain mu-opioid receptors.
Nascimento DC; Andersen ML; Hipólide DC; Nobrega JN; Tufik S
Behav Brain Res; 2007 Mar; 178(2):216-20. PubMed ID: 17239968
[TBL] [Abstract][Full Text] [Related]
40. Mu, delta, and kappa opioid receptor agonists induce peripheral antinociception by activation of endogenous noradrenergic system.
Romero TR; Guzzo LS; Duarte ID
J Neurosci Res; 2012 Aug; 90(8):1654-61. PubMed ID: 22473744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
